Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)

Autor: Dawn L. Hershman, Bingshu E. Chen, Claire Sathe, Wendy R. Parulekar, Julie Lemieux, Jennifer A. Ligibel, Karen A. Gelmon, Timothy J. Whelan, Pamela J. Goodwin
Rok vydání: 2023
Předmět:
Zdroj: Breast Cancer Research and Treatment. 200:93-102
ISSN: 1573-7217
0167-6806
DOI: 10.1007/s10549-023-06922-2
Databáze: OpenAIRE